Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study

Meyran, D; Petit, A; Guilhot, J; Suttorp, M; Sedlacek, P; De Bont, E; Li, CK; Kalwak, K; Lausen, B; Culic, S; de Moerloose, B; Biondi, A; Millot, F

Meyran, D (corresponding author), Hop Robert Debre, 48 Blvd Serurier, F-75019 Paris, France.

EUROPEAN JOURNAL OF CANCER, 2020; 137 (): 224

Abstract

Background: Chronic myeloid leukaemia (CML) is a rare disease in children. The frequency and outcome of children evolving to accelerated phase (AP) or......

Full Text Link